Onkologie. 2015:9(2):82-84

Liver metastases, the role of interventional radiology

Vlastimil Válek1, Tomáš Andrašina1, Igor Kiss2, Lenka Ostřížková3
1 Radiologická klinika FN Brno a LF MU v Brně
2 Klinika komplexní onkologické péče MOU Brno a LF MU v Brně
3 Interní hematologická a onkologická klinika FN Brno a LF MU v Brně

Unresectable colorectal liver metastases have a 1- and 2-year survival of 55 % and 33 % with current systemic therapies. Currently image-

-guided liver-directed therapy like trans-arterial chemoembolization (TACE), hepatic arterial infusion (HAI) and termoablation (RFA) has

a growing role in the therapy of patients with liver metastases. Endovascular and percutaneous hepatic-directed therapy offers the dual

benefit of true local neoplastic control and reduction of sideeffects. The development of new embolizing agents, such as DC beads (DEB)

loaded with doxorubicin and irinotecan, permits better standardization and definition of protocols, making the procedures less linked

to criteria of different hospitals and personal experiences of interventional radiologists.

Keywords: drug-eluting beads, RFA, microwaves, liver metastases, chemoembolization, DEBIRI, colorectal cancer, liver-directed therapy

Published: April 10, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Válek V, Andrašina T, Kiss I, Ostřížková L. Liver metastases, the role of interventional radiology. Onkologie. 2015;9(2):82-84.
Download citation

References

  1. Michael A.Ch. Liver-Directed Treatments for Metastatic Colorectal Cancer. Current Treatment Options in Oncology 2014; 15: 456-464. Go to original source... Go to PubMed...
  2. Veltri A., Guarnieri T., Gazzera C. Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival. Radiol med 2012; 117: 1139-1151. Go to original source... Go to PubMed...
  3. Hong K., Georgiades C.J. Radiofrequency ablation: mechanism of action and devices. Vasc. Interv. Radiol. 2010; 21 (8 Suppl): 179-186. Go to original source...
  4. Goldberg S.N., Grassi C.J., Cardella J.F. et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235: 728-739. Go to original source... Go to PubMed...
  5. Gillams A.R. The use of radiofrequency in cancer. Br J Cancer 2005; 92: 1825-1829. Go to original source... Go to PubMed...
  6. Lencioni R., Crocetti L., Cioni D. et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 2004; 39: 689-697. Go to original source... Go to PubMed...
  7. Suppiah A., White T.J., Roy-Choudhury S.H. et al. Longterm results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases; final outcomes. Dig Surg. 2007; 24: 358-360. Go to original source... Go to PubMed...
  8. Weng M., Zhang Y., Zhou D. et al. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One 2012; 7: e45493. Go to original source... Go to PubMed...
  9. Hur H., Ko Y.T., Min B.S. et al. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg 2009; 197: 728-736. Go to original source... Go to PubMed...
  10. Vogl T.J., Zangos S., Eichler K. Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol. 2007;17 (4): 1025-1034. Go to original source...
  11. Allard M.A., Malka D. Place of hepatic intra-arterial chemotherapy in the treatment of colorectal liver metastases. J Visc Surg. 2014; 151 Suppl 1: S21-24. Go to original source... Go to PubMed...
  12. Nishiofuku H., Tanaka T., Matsuoka M. et al. Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II study. J Vasc Interv Radiol. 2013; 24 (1): 56-65. Go to original source... Go to PubMed...
  13. Fiorentini G., Aliberti C., Mulazzani L. et al. Chemoembolization in colorectal liver metastases: the rebirth. Anticancer Res. 2014; 34 (2): 575-584.
  14. Richardson A.J., Laurence J.M., Lam V.W.Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review. J Vasc Interv Radiol. 2013; 24 (8): 1209-1217. Go to original source... Go to PubMed...
  15. Clark T.W. Chemoembolization for colorectal liver metastases after FOLFOX failure. J Vasc Interv Radiol. 2013; 24 (1): 56-65. Go to original source... Go to PubMed...
  16. Albert M., Kiefer M.V., Sun W., Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol. Cancer 2011; 117 (2): 343-352. Go to original source...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.